Iqvia Holdings Inc 's Revenue in the fiscal year 2025 $ 16,310.00 millions
Iqvia Holdings Inc 's Revenue in the fiscal year 2024 $ 15,405.00 millions
Iqvia Holdings Inc 's Revenue in the fiscal year 2023 $ 14,984.00 millions
Iqvia Holdings Inc 's Revenue in the fiscal year 2022 $ 14,410.00 millions
Iqvia Holdings Inc 's Revenue in the fiscal year 2021 $ 13,874.00 millions
IQV Revenue first quarter 2026 Y/Y Growth Comment
Iqvia Holdings Inc achieved in the first quarter 2026, above Company average Revenue improvement of 8.41% year on year, to $ 4,151.00 millions.
Looking into first quarter 2026 results within Medical Laboratories industry 11 other companies have achieved higher Revenue growth. While Iqvia Holdings Inc ' s Revenue increase of 8.41% ranks overall at the positon no. 921 in the first quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Iqvia Holdings Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
18.38 %
-0.43 %
-100 %
(Dec 31 2020)
IQV's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2026 Iqvia Holdings Inc disclosed fall in Revenue from the fourth quarter by -4.88% to $ 4,151.00 millions, from $ 4,364.00 millions achived in the previous reporting period.
But that's not important problem, as Iqvia Holdings Inc 's Revenue generally seem to plunge in this quarter.
Within Medical Laboratories industry 6 other companies have achieved higher Revenue quarter on quarter growth. While Iqvia Holdings Inc 's Revenue growth quarter on quarter, overall rank is 866.
In the I. Quarter 2026 Iqvia Holdings Inc disclosed fall in Revenue from the fourth quarter by -4.88% to $ 4,151.00 millions, from $ 4,364.00 millions achived in the previous reporting period.
But that's not important problem, as Iqvia Holdings Inc 's Revenue generally seem to plunge in this quarter.
Within Medical Laboratories industry 6 other companies have achieved higher Revenue quarter on quarter growth. While Iqvia Holdings Inc 's Revenue growth quarter on quarter, overall rank is 866.
Iqvia Holdings Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
12 Months Ending (Mar 31 2025)
Cumulative Revenue 12 Months Ending
$ 16,632.00
$ 16,310.00
$ 15,904.00
$ 15,700.00
$ 15,497.00
Y / Y Revenue Growth (TTM)
7.32 %
5.87 %
3.85 %
3.6 %
2.84 %
Year on Year Revenue Growth Overall
Ranking
# 825
# 884
# 1855
# 1612
# 1359
Seqeuential Revenue Change (TTM)
1.97 %
2.55 %
1.3 %
1.31 %
0.6 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2401
# 1010
# 2055
# 2029
# 1684
Cumulative Revenue growth Comment
Iqvia Holdings Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 7.32% year on year, to $ 16,632 millions if the fiscal year would have ended in Mar 31 2026. Iqvia Holdings Inc 's trailing twelve months Revenue growth was higher than company's average -1.88% and higher than 5.87% growth in Dec 31 2025. But from twelve months ended Dec 31 2025 rise was beneth at 1.97 % from $16310 millions achieved in the period from Dec 31 2025 to Mar 31 2025. Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at -1.72%. The momentum is even more impressive from twelve months ended Dec 31 2025 exhibited at 1.97 % increase from $16310 millions in the period from Dec 31 2025 to Mar 31 2025.
In the Healthcare sector 104 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 825, from total ranking in previous quarter at 884.
Iqvia Holdings Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 7.32% year on year, to $ 16,632 millions if the fiscal year would have ended in Mar 31 2026. Iqvia Holdings Inc 's trailing twelve months Revenue growth was higher than company's average -1.88% and higher than 5.87% growth in Dec 31 2025. But from twelve months ended Dec 31 2025 rise was beneth at 1.97 % from $16310 millions achieved in the period from Dec 31 2025 to Mar 31 2025. Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at -1.72%. The momentum is even more impressive from twelve months ended Dec 31 2025 exhibited at 1.97 % increase from $16310 millions in the period from Dec 31 2025 to Mar 31 2025.
In the Healthcare sector 104 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 825, from total ranking in previous quarter at 884.
About Iqvia Holdings Inc Revenue Growth Rates (IQV), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
14.60%